Robert E. Mosser

Array ( [id] => 7511494 [patent_doc_number] => 20110257204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Penciclovir or Famciclovir for Treatment of Recurrent Genital Herpes with a One-Day Application' [patent_app_type] => utility [patent_app_number] => 13/028680 [patent_app_country] => US [patent_app_date] => 2011-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4183 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257204.pdf [firstpage_image] =>[orig_patent_app_number] => 13028680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8866647 [patent_doc_number] => 20130150350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication' [patent_app_type] => utility [patent_app_number] => 13/576304 [patent_app_country] => US [patent_app_date] => 2011-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25276 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13576304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186762 [patent_doc_number] => 20110124721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'METHODS OF TREATING TRAUMATIC BRAIN INJURY BY ADMINISTERING BAICALEIN PREPARATION' [patent_app_type] => utility [patent_app_number] => 13/016769 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8644 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124721.pdf [firstpage_image] =>[orig_patent_app_number] => 13016769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8496489 [patent_doc_number] => 20120295898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'Antiviral Therapy' [patent_app_type] => utility [patent_app_number] => 13/575380 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5845 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586939 [patent_doc_number] => 20130005760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'HETEROCYCLIC COMPOUND HAVING AZOLE GROUP' [patent_app_type] => utility [patent_app_number] => 13/574492 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26729 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046559 [patent_doc_number] => 20110206638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR REDUCING THE MUTATION RATE OF VIRUSES' [patent_app_type] => utility [patent_app_number] => 13/009737 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 61042 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206638.pdf [firstpage_image] =>[orig_patent_app_number] => 13009737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8607194 [patent_doc_number] => 20130012506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'ANTI-INFECTIVE PYRIDO (1,2-A) PYRIMIDINES' [patent_app_type] => utility [patent_app_number] => 13/518292 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 60747 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760178 [patent_doc_number] => 08420698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Histone deacetylase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/977335 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15246 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12977335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987377 [patent_doc_number] => 20110098341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'USE OF ID4 FOR DIAGNOSIS AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/978286 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4991 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098341.pdf [firstpage_image] =>[orig_patent_app_number] => 12978286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039409 [patent_doc_number] => 20110092458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases' [patent_app_type] => utility [patent_app_number] => 12/976599 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7992 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092458.pdf [firstpage_image] =>[orig_patent_app_number] => 12976599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8567301 [patent_doc_number] => 20120329871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'ANTIMICROBIAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/517455 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15678 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13517455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968969 [patent_doc_number] => 20110150836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'METHODS OF TREATING HBV AND HCV INFECTION' [patent_app_type] => utility [patent_app_number] => 12/970213 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15012 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150836.pdf [firstpage_image] =>[orig_patent_app_number] => 12970213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8756064 [patent_doc_number] => 20130090367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'Compositions and Methods for Inhibiting Human Host Factors Required for Influenza Virus Replication' [patent_app_type] => utility [patent_app_number] => 13/514783 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 91882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8416620 [patent_doc_number] => 20120244120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'INHIBITORS OF HEMOPOIETIC CELL KINASE (P59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION' [patent_app_type] => utility [patent_app_number] => 13/514644 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 50496 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8607189 [patent_doc_number] => 20130012502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'Pharmaceutical or Veterinary Antiviral Compositions' [patent_app_type] => utility [patent_app_number] => 13/513877 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 4022 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8449976 [patent_doc_number] => 20120260922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'TOPICAL USE OF HYDROXYTYROSOL AND DERIVATIVES FOR THE PREVENTION OF HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 13/513061 [patent_app_country] => US [patent_app_date] => 2010-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9747 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568105 [patent_doc_number] => 20110288168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'HISTONE DEACETYLASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/955470 [patent_app_country] => US [patent_app_date] => 2010-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25158 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288168.pdf [firstpage_image] =>[orig_patent_app_number] => 12955470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8523360 [patent_doc_number] => 20120322768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING PROTOZOAN INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/511560 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11989 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453846 [patent_doc_number] => 20120264793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'Pharmaceutical Use of 2\',2-Bis-Thiazole Non-Nucleoside Compounds as Hepatitis C Virus Inhibitor' [patent_app_type] => utility [patent_app_number] => 13/518549 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2147 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580895 [patent_doc_number] => 20110294778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'HEPATITIS C INHIBITOR COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/952794 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39014 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294778.pdf [firstpage_image] =>[orig_patent_app_number] => 12952794 [rel_patent_id] =>[rel_patent_doc_number] =>)